AI Mentions Your Drug Brand 24/7 — Are You Watching?
The Invisible Conversation Shaping Your Drug’s Reputation Somewhere right now, a patient is asking an AI chatbot whether their statin
The Invisible Conversation Shaping Your Drug’s Reputation Somewhere right now, a patient is asking an AI chatbot whether their statin
Pharmaceutical brands are losing control of their product narrative — not in the press, not at the pharmacy counter, but
Pharmaceutical companies face a new blind spot as patients migrate from search engines to Large Language Models (LLMs) for medical
The era of the ten-blue-link search result is ending. For pharmaceutical marketers, the transition from Google Search to Large Language
The Problem No One Is Watching Closely Enough Somewhere between a patient typing symptoms into a chatbot and a physician
How ChatGPT, Gemini, and a dozen other AI chatbots became the most unmonitored channel in pharmaceutical brand strategy — and
Sign in or create a free account to read this DrugChatter article